CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling

Wei‐Liang Chen(National Defense Medical Center), James Yi‐Hsin Chan(Tri-Service General Hospital)
Oncotarget
August 9, 2016
Cited by 25


Related Papers